[Effect of certain anti-inflammatory preparations on experimental hyperbilirubienmia].
D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000983:Antipyrine / Q000627:therapeutic use; D001652:Bile Ducts; D002251:Carbon Tetrachloride / Q000494:pharmacology; D006932:Hyperbilirubinemia / Q000139:chemically induced / Q000188:drug therapy*; D008026:Ligation; D009536:Niacinamide / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D051381:Rats
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D009536:Niacinamide; D011239:Prednisolone; D002251:Carbon Tetrachloride; D010653:Phenylbutazone; D000983:Antipyrine
O vliianii nekotorykh protivovospalitel'nykh preparatov na éksperimental'nuiu giperbilirubinemiiu.